Article: For skin types IV-VI, Sculptra just as effective.(NEWS)

MAUI, HAWAII -- Injectable poly-L-lactic acid is at least as safe and effective in patients with darker skin as in those with Fitzpatrick skin types I-III, according to a multicenter postmarketing study.

The ongoing study also demonstrated that there were no sex differences in response to treatment. The study was mandated by the Food and Drug Administration as a condition of Sculptra's approval for correction of HIV-related facial lipoatrophy because the original clinical trials were heavily skewed toward white males, Dr. Douglas Mest explained at the annual Hawaii dermatology seminar sponsored by Skin Disease Education Foundation.

"What I found most ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!